144 related articles for article (PubMed ID: 18937296)
1. Replication of a rare protective allele in the noradrenaline transporter gene and ADHD.
Xu X; Hawi Z; Brookes KJ; Anney R; Bellgrove M; Franke B; Barry E; Chen W; Kuntsi J; Banaschewski T; Buitelaar J; Ebstein R; Fitzgerald M; Miranda A; Oades RD; Roeyers H; Rothenberger A; Sergeant J; Sonuga-Barke E; Steinhausen HC; Faraone SV; Gill M; Asherson P
Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1564-7. PubMed ID: 18937296
[TBL] [Abstract][Full Text] [Related]
2. Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients.
Angyal N; Horvath EZ; Tarnok Z; Richman MJ; Bognar E; Lakatos K; Sasvari-Szekely M; Nemoda Z
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):122-128. PubMed ID: 29374517
[TBL] [Abstract][Full Text] [Related]
3. No evidence of an association between norepinephrine transporter gene polymorphisms and attention deficit hyperactivity disorder: a family-based and case-control association study in a Korean sample.
Cho SC; Kim JW; Kim BN; Hwang JW; Park M; Kim SA; Cho DY; Yoo HJ; Chung US; Son JW; Park TW
Neuropsychobiology; 2008; 57(3):131-8. PubMed ID: 18552510
[TBL] [Abstract][Full Text] [Related]
4. A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD).
Ramoz N; Boni C; Downing AM; Close SL; Peters SL; Prokop AM; Allen AJ; Hamon M; Purper-Ouakil D; Gorwood P
Neuropsychopharmacology; 2009 Aug; 34(9):2135-42. PubMed ID: 19387424
[TBL] [Abstract][Full Text] [Related]
5. Association studies of -3081(A/T) polymorphism of norepinephrine transporter gene with attention deficit/hyperactivity disorder in Korean population.
Joung Y; Kim CH; Moon J; Jang WS; Yang J; Shin D; Lee S; Kim KS
Am J Med Genet B Neuropsychiatr Genet; 2010 Mar; 153B(2):691-694. PubMed ID: 19685476
[TBL] [Abstract][Full Text] [Related]
6. No evidence for association between a functional promoter variant of the Norepinephrine Transporter gene SLC6A2 and ADHD in a family-based sample.
Renner TJ; Nguyen TT; Romanos M; Walitza S; Röser C; Reif A; Schäfer H; Warnke A; Gerlach M; Lesch KP
Atten Defic Hyperact Disord; 2011 Sep; 3(3):285-9. PubMed ID: 21739117
[TBL] [Abstract][Full Text] [Related]
7. Differential association between the norepinephrine transporter gene and ADHD: role of sex and subtype.
Sengupta SM; Grizenko N; Thakur GA; Bellingham J; DeGuzman R; Robinson S; TerStepanian M; Poloskia A; Shaheen SM; Fortier ME; Choudhry Z; Joober R
J Psychiatry Neurosci; 2012 Feb; 37(2):129-37. PubMed ID: 22297068
[TBL] [Abstract][Full Text] [Related]
8. Further evidence of association between two NET single-nucleotide polymorphisms with ADHD.
Kim JW; Biederman J; McGrath CL; Doyle AE; Mick E; Fagerness J; Purcell S; Smoller JW; Sklar P; Faraone SV
Mol Psychiatry; 2008 Jun; 13(6):624-30. PubMed ID: 17876324
[TBL] [Abstract][Full Text] [Related]
9. The possible involvement of genetic variants of NET1 in the etiology of attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder.
Liu L; Cheng J; Li H; Yang L; Qian Q; Wang Y
J Child Psychol Psychiatry; 2015 Jan; 56(1):58-66. PubMed ID: 24942521
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive phenotype/genotype analyses of the norepinephrine transporter gene (SLC6A2) in ADHD: relation to maternal smoking during pregnancy.
Thakur GA; Sengupta SM; Grizenko N; Choudhry Z; Joober R
PLoS One; 2012; 7(11):e49616. PubMed ID: 23185385
[TBL] [Abstract][Full Text] [Related]
11. A haplotype of the norepinephrine transporter gene (SLC6A2) is associated with visual memory in attention-deficit/hyperactivity disorder.
Shang CY; Chiang HL; Gau SS
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():89-96. PubMed ID: 25554436
[TBL] [Abstract][Full Text] [Related]
12. Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: a preliminary study.
Biederman J; Kim JW; Doyle AE; Mick E; Fagerness J; Smoller JW; Faraone SV
Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1511-8. PubMed ID: 18937309
[TBL] [Abstract][Full Text] [Related]
13. Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults.
Retz W; Rösler M; Kissling C; Wiemann S; Hünnerkopf R; Coogan A; Thome J; Freitag C
J Neural Transm (Vienna); 2008; 115(2):323-9. PubMed ID: 17994190
[TBL] [Abstract][Full Text] [Related]
14. Intelligence in DSM-IV combined type attention-deficit/hyperactivity disorder is not predicted by either dopamine receptor/transporter genes or other previously identified risk alleles for attention-deficit/hyperactivity disorder.
Sonuga-Barke EJ; Brookes KJ; Buitelaar J; Anney R; Bitsakou P; Baeyens D; Buschgens C; Chen W; Christiansen H; Eisenberg J; Kuntsi J; Manor I; Meliá A; Mulligan A; Rommelse N; Müller UC; Uebel H; Banaschewski T; Ebstein R; Franke B; Gill M; Miranda A; Oades RD; Roeyers H; Rothenberger A; Sergeant J; Steinhausen HC; Thompson M; Taylor E; Asherson P; Faraone SV
Am J Med Genet B Neuropsychiatr Genet; 2008 Apr; 147(3):316-9. PubMed ID: 18023044
[TBL] [Abstract][Full Text] [Related]
15. Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorder.
Kim BN; Kim JW; Hong SB; Cho SC; Shin MS; Yoo HJ
Behav Brain Funct; 2010 Oct; 6():57. PubMed ID: 20929549
[TBL] [Abstract][Full Text] [Related]
16. A case-control association study of serotonin 1A receptor gene and tryptophan hydroxylase 2 gene in attention deficit hyperactivity disorder.
Shim SH; Hwangbo Y; Kwon YJ; Jeong HY; Lee BH; Hwang JA; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):974-9. PubMed ID: 20470849
[TBL] [Abstract][Full Text] [Related]
17. Possible effect of norepinephrine transporter polymorphisms on methylphenidate-induced changes in neuropsychological function in attention-deficit hyperactivity disorder.
Park S; Kim JW; Yang YH; Hong SB; Park MH; Kim BN; Shin MS; Yoo HJ; Cho SC
Behav Brain Funct; 2012 May; 8():22. PubMed ID: 22591463
[TBL] [Abstract][Full Text] [Related]
18. DNA pooling analysis of 21 norepinephrine transporter gene SNPs with attention deficit hyperactivity disorder: no evidence for association.
Xu X; Knight J; Brookes K; Mill J; Sham P; Craig I; Taylor E; Asherson P
Am J Med Genet B Neuropsychiatr Genet; 2005 Apr; 134B(1):115-8. PubMed ID: 15719398
[TBL] [Abstract][Full Text] [Related]
19. Testing for the mediating role of endophenotypes using molecular genetic data in a twin study of ADHD traits.
Pinto R; Asherson P; Ilott N; Cheung CH; Kuntsi J
Am J Med Genet B Neuropsychiatr Genet; 2016 Oct; 171(7):982-92. PubMed ID: 27230021
[TBL] [Abstract][Full Text] [Related]
20. Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder.
Lu AT; Ogdie MN; Järvelin MR; Moilanen IK; Loo SK; McCracken JT; McGough JJ; Yang MH; Peltonen L; Nelson SF; Cantor RM; Smalley SL
Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1488-94. PubMed ID: 18213623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
